Hyderabad-based pharma player Laurus Labs has received a licence from the Defence Research & Development Organisation (DRDO) for manufacturing and marketing Covid-19 drug 2-Deoxy-D-Glucose (2-DG) in India. The licence to Laurus Labs has been granted by DRDO as part of efforts to make the drug affordable and accessible to patients.
DRDO had recently invited expression of interest (EoI) from other pharma companies for manufacturing this drug and had said it would grant licences to 15 companies on a first-come, first-served basis. Meanwhile, the Council of Scientific & Industrial Research institution Indian Institute of Chemical Technology (CSIR-IICT) has been licencing the know-how for 2-DG synthesis to other companies, including Lee Pharma, Suven Pharma, Anthem Biosciences and Nosch Labs.
Weekly Current Affairs One-Liners Current Affairs 2026 plays a very important role in competitive examinations…
Valleys are low areas of land that lie between hills or mountains. They are formed…
Sandwiches are one of the most popular foods in the world. They are simple, quick…
The Government of India has appointed Rohit Jain as the Deputy Governor of the Reserve…
The Government of India has notified the Citizenship (Amendment) Rules, 2026 and introduced the important…
The Reserve Bank of India have announced that 98.47% of ₹2,000 Indian currency notes have…